Table S1. Gene fold changes in T47D cells transfected with HER2â3âUTR or control vector. (XLSX 891 kb
- Comparison of the genes altered by transgelin overexpression in RKO and DLD-1 cells. Table shows g...
Figure. S1. a Expression level of AFF3 and SLC116A14 in breast cancer tissues compared with noncance...
Figure S1. Wild-type p53 expression inversely correlates with HER2 mRNA levels. HeLa (A) and Saos-2 ...
Table S2. Gene-set enrichment analysis in T47D cells transfected with HER2â3âUTR or control vect...
Figure S5. Reciprocal ceRNA activity between HER2 and HER3 3âUTR. HER2 3âUTR-luciferase reporter...
Figure S2. Effect of trastuzumab on HER2 and HER3 levels. FACS analysis of HER2 and HER3 levels in A...
Figure S6. Effect of trastuzumab on HER2 protein levels. Western blot analysis of HER2 levels in AU5...
Table S3. Shared miRNAs binding sites prediction in human HER2 and HER4 3âUTR. (XLSX 12 kb
Figure S4. Correlation between miR-125a/b and EGFR family proteins in HER2 positive breast cancer pa...
Figure S3. Combinatory treatment with HER3 siRNA and trastuzumab is useful for overcoming trastuzuma...
Table S4. miRNAs binding sites prediction in human HER2 and HER3 3âUTR. (XLSX 26 kb
Figure S1. Effect of trastuzumab on miR-125a/b levels. Real-time PCR analysis of miR-125a and miR-12...
Table S2. The sequences of the primers used for HER2 promoter analysis. (PDF 336 kb
Table S1. The sequences of the primers used for HER2 and p53 analysis. (PDF 339 kb
Figure S1. SNAI2 and E-cadherin protein levels following siRNA-mediated SNAI2 knockdown. MCF-7-based...
- Comparison of the genes altered by transgelin overexpression in RKO and DLD-1 cells. Table shows g...
Figure. S1. a Expression level of AFF3 and SLC116A14 in breast cancer tissues compared with noncance...
Figure S1. Wild-type p53 expression inversely correlates with HER2 mRNA levels. HeLa (A) and Saos-2 ...
Table S2. Gene-set enrichment analysis in T47D cells transfected with HER2â3âUTR or control vect...
Figure S5. Reciprocal ceRNA activity between HER2 and HER3 3âUTR. HER2 3âUTR-luciferase reporter...
Figure S2. Effect of trastuzumab on HER2 and HER3 levels. FACS analysis of HER2 and HER3 levels in A...
Figure S6. Effect of trastuzumab on HER2 protein levels. Western blot analysis of HER2 levels in AU5...
Table S3. Shared miRNAs binding sites prediction in human HER2 and HER4 3âUTR. (XLSX 12 kb
Figure S4. Correlation between miR-125a/b and EGFR family proteins in HER2 positive breast cancer pa...
Figure S3. Combinatory treatment with HER3 siRNA and trastuzumab is useful for overcoming trastuzuma...
Table S4. miRNAs binding sites prediction in human HER2 and HER3 3âUTR. (XLSX 26 kb
Figure S1. Effect of trastuzumab on miR-125a/b levels. Real-time PCR analysis of miR-125a and miR-12...
Table S2. The sequences of the primers used for HER2 promoter analysis. (PDF 336 kb
Table S1. The sequences of the primers used for HER2 and p53 analysis. (PDF 339 kb
Figure S1. SNAI2 and E-cadherin protein levels following siRNA-mediated SNAI2 knockdown. MCF-7-based...
- Comparison of the genes altered by transgelin overexpression in RKO and DLD-1 cells. Table shows g...
Figure. S1. a Expression level of AFF3 and SLC116A14 in breast cancer tissues compared with noncance...
Figure S1. Wild-type p53 expression inversely correlates with HER2 mRNA levels. HeLa (A) and Saos-2 ...
DOI
Add to ORKG